Table 3.
Gene that was knocked down | Trial 1 | Trial 2 |
---|---|---|
CG32833 | n.s. | No data |
CG9897 | n.s | n.s |
CG32834 | F1,333 = 189.5* | F1,127 = 4.06* |
CG9897 and CG32834 | n.s | n.s. |
CG9897 and CG32833 | n.s | No data |
CG32834 and CG32833 | n.s | No data |
CG9897, CG32834, and CG32833 | n.s. | No data |
Note.—Data were analyzed using an ANOVA in SPSS after testing for normality with the Kolmogorv–Smirnov test.
aIn Trial 1, control females or females knocked down for each female gene (individually and in combination) were mated to control males or males knocked down for CG32833 (on Day 0). N = 32–58 females per treatment.
bIn Trial 2, control females or females knocked down for each female gene (individually and in combination) were mated to wild-type males (on Day 0). N = 15–40 females per treatment.
cn.s.: not significant; no data: not tested.
*P ≤ 0.05.